USA - NASDAQ:CFRX - US2123264093 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to CFRX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-04-13 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-07-14 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-07-14 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-07-14 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-06-08 | WBB Securities | Upgrade | Buy -> Strong Buy |
| 2022-02-16 | SVB Leerink | Maintains | Outperform |
| 2022-02-02 | WBB Securities | Upgrade | Speculative Buy -> Buy |
| 2021-09-09 | SVB Leerink | Initiate | Outperform |
| 2021-03-31 | WBB Securities | Initiate | Speculative Buy |
7 analysts have analysed CFRX and the average price target is 5.1 USD. This implies a price increase of 2100.17% is expected in the next year compared to the current price of 0.2318.
The consensus rating for CONTRAFECT CORP (CFRX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering CONTRAFECT CORP (CFRX) is 7.